GO:0160016 CCACCA tRNA nucleotidyltransferase activity

GO:0160016, CCACCA tRNA nucleotidyltransferase activity, is a molecular function that catalyzes the addition of two CTP and one ATP to a tRNA molecule already possessing a 3' CCA end, resulting in a 3' CCACCA extension and the release of three diphosphate molecules. This activity represents a distinct enzymatic step beyond the canonical CCA-adding process, and it is classified under the molecular_function aspect of the Gene Ontology. Understanding this activity is important because tRNA 3' end modifications can affect tRNA maturation, stability, and function in translation. Although the CCACCA modification is not as widely studied as the initial CCA addition, emerging evidence from cold-adapted tRNA nucleotidyltransferases suggests that such extensions may play roles in adapting to environmental conditions and maintaining translational fidelity. Researchers investigating tRNA biology, enzyme mechanism, and stress responses will find GO:0160016 relevant for exploring how tRNA ends are dynamically remodeled. This article provides a comprehensive overview of the definition, mechanism, key genes, disease associations, and research methods for studying CCACCA tRNA nucleotidyltransferase activity, based on the available literature.

According to the Gene Ontology, GO:0160016 is defined as the catalysis of the reaction: a tRNA with a 3' CCA end + 2 CTP + ATP = a tRNA with a 3' CCACCA end + 3 diphosphate. In simpler terms, this enzyme takes a tRNA that already has the standard CCA tail and adds two more cytidines and one more adenosine, creating a CCACCA tail. This activity is a type of tRNA nucleotidyltransferase activity, but it specifically extends the existing CCA end rather than synthesizing it from scratch.

CCACCA tRNA nucleotidyltransferase activity is important because it represents a novel layer of tRNA 3' end modification that could influence tRNA stability, aminoacylation efficiency, and translation. While the canonical CCA addition is essential for tRNA function, the further extension to CCACCA may serve regulatory or adaptive roles, as suggested by studies on cold-adapted tRNA nucleotidyltransferases that show tradeoffs in activity, stability, and fidelity. Understanding this activity can shed light on how cells fine-tune translation under different conditions and may reveal new targets for biotechnology or therapeutic intervention.

The following genes and proteins are known to be involved in or related to CCACCA tRNA nucleotidyltransferase activity, based on the available literature.

The activity of CCACCA tRNA nucleotidyltransferase may be regulated at multiple levels. Environmental factors such as temperature can influence enzyme activity, stability, and fidelity, as demonstrated in cold-adapted tRNA nucleotidyltransferases. Additionally, the availability of substrates (CTP and ATP) and the presence of tRNA molecules with a CCA end can affect the reaction rate. Post-translational modifications or interactions with other proteins might also modulate the enzyme's function, although specific regulators have not been extensively characterized. Further research is needed to fully understand the regulatory mechanisms governing this activity.

Defects in tRNA processing, including 3' end modifications, have been linked to various human diseases such as neurodegeneration and mitochondrial disorders. While the specific role of CCACCA tRNA nucleotidyltransferase activity in disease is not yet established, aberrant tRNA 3' end processing could contribute to pathologies by affecting translation fidelity and protein homeostasis. Cold-adapted enzyme studies highlight the importance of fidelity, suggesting that mutations altering fidelity could have deleterious effects.

Altered tRNA modification patterns are observed in cancer, where they can promote tumorigenesis by enhancing translation of oncogenic mRNAs. The CCACCA modification might influence tRNA stability or aminoacylation, potentially impacting cancer cell proliferation. However, direct evidence linking GO:0160016 to cancer is currently lacking, and further research is needed.

Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease have been associated with tRNA processing defects. The CCACCA extension could play a role in maintaining tRNA function in neurons, and its dysregulation might contribute to disease progression. Studies on cold-adapted tRNA nucleotidyltransferases provide a framework for understanding how changes in enzyme activity and fidelity could affect cellular stress responses.

In vitro assays using recombinant tRNA nucleotidyltransferase and synthetic tRNA substrates with a 3' CCA end can measure the addition of CTP and ATP by monitoring diphosphate release or using radiolabeled nucleotides. These assays are essential for determining kinetic parameters and fidelity.

Advanced RNA sequencing techniques, such as tRNA-seq or modification-specific sequencing, can detect the presence of CCACCA extensions on tRNAs in cells. Comparing wild-type and knockout cells can reveal the physiological impact of the modification.

CRISPR knockout of the tRNA nucleotidyltransferase gene can abolish CCACCA activity, allowing researchers to study its cellular functions. Point mutations can be introduced to dissect catalytic residues, while knock-in of tagged versions enables localization and interaction studies.

X-ray crystallography or cryo-EM of the enzyme in complex with tRNA and nucleotides can provide insights into the catalytic mechanism and fidelity determinants. Homology modeling based on related nucleotidyltransferases can also guide mutagenesis.

Researchers studying CCACCA tRNA nucleotidyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in tRNA modification, translation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout and point mutation to knock-in and overexpression models, as well as library screening and bioinformatics support.

CCACCA tRNA nucleotidyltransferase activity (GO:0160016) is a specialized molecular function that extends the 3' end of tRNAs beyond the canonical CCA tail. Although research on this activity is still emerging, studies on cold-adapted tRNA nucleotidyltransferases have provided valuable insights into its mechanism, fidelity, and potential regulation. Understanding this activity could illuminate new aspects of tRNA biology and translation control. With the help of advanced CRISPR models and biochemical assays, researchers can further explore the roles of CCACCA modification in health and disease.